KRT14 and breast cancer: Previous studies demonstrate that K14− can become K14+ to lead the invasive front during metastasis of mouse mammary tumor virus polyomavirus middle T-antigen (MMTV-PyMT) luminal metastatic mouse model of breast cancer [12].